Old Web
English
Sign In
Acemap
>
Paper
>
69P The diabetes drug canagliflozin sensitizes non-small cell lung cancer (NSCLC) to radiotherapy and chemotherapy
69P The diabetes drug canagliflozin sensitizes non-small cell lung cancer (NSCLC) to radiotherapy and chemotherapy
2018
Theodoros Tsakiridis
Linda Villani
Lindsay A. Broadfield
Katarina Marcinko
Evangelia Tsakiridis
Peter M. Ellis
Paola Muti
Gregory R. Steinberg
Keywords:
Canagliflozin
non-small cell lung cancer (NSCLC)
Drug
General surgery
Radiation therapy
Diabetes mellitus
Chemotherapy
Medicine
Pathology
Oncology
Internal medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]